Related Experiment Videos

Pathogenesis of murine encephalitis limited by defective interfering particles. An immunohistochemical study

I V Plakhov1, C Aoki, C S Reiss

  • 1Department of Biology, New York University, NY 10003-6688, USA.

Insights

Defective interfering (DI) particles reduced mortality and morbidity in vesicular stomatitis virus (VSV)-induced encephalitis in mice. DI particles limited viral spread in the central nervous system, showing therapeutic potential.

Area of Science:

  • Virology
  • Immunology
  • Neuroscience

Background:

  • Viral encephalitis poses a significant health threat.
  • Vesicular stomatitis virus (VSV) is a model pathogen for studying encephalitis.
  • Defective interfering (DI) particles are variants of viruses that can interfere with standard virus replication.

Purpose of the Study:

  • To investigate the effect of DI particles on VSV-induced viral encephalitis in BALB/c mice.
  • To determine if DI particles can alter disease progression and mortality.
  • To analyze the dissemination pathways of VSV antigen within the central nervous system (CNS) in the presence of DI particles.

Main Methods:

  • BALB/c mice were intranasally inoculated with standard VSV and its DI particles.
  • Morbidity and mortality were monitored.
  • Immunohistochemical analysis was performed on brain tissue from 121 mice to track VSV antigen dissemination.
  • Different concentrations and UV-irradiated DI particles were tested.

Main Results:

  • Addition of high-dose DI particles (10^7 PFU equivalents) to VSV (10^5 PFU) reduced morbidity and mortality but did not delay disease onset.
  • Lower doses or UV-irradiated DI particles did not show these protective effects.
  • Immunohistochemistry revealed that DI particles limited VSV antigen dissemination pathways within the CNS.
  • At day 4 post-inoculation, VSV antigen was restricted to outer layers of the olfactory bulb in mice treated with DI particles, unlike deeper invasion in controls.

Conclusions:

  • DI particles demonstrate potential as therapeutic agents against VSV-induced encephalitis.
  • The early stages of viral replication at the inoculation site may be critical in determining mortality.
  • DI particles modulate the host's immune response by limiting viral spread within the CNS.

Related Concept Videos